1. Home
  2. PBPB vs DCTH Comparison

PBPB vs DCTH Comparison

Compare PBPB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBPB
  • DCTH
  • Stock Information
  • Founded
  • PBPB 1977
  • DCTH 1988
  • Country
  • PBPB United States
  • DCTH United States
  • Employees
  • PBPB N/A
  • DCTH N/A
  • Industry
  • PBPB Restaurants
  • DCTH Medical/Dental Instruments
  • Sector
  • PBPB Consumer Discretionary
  • DCTH Health Care
  • Exchange
  • PBPB Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • PBPB 305.0M
  • DCTH 630.4M
  • IPO Year
  • PBPB 2013
  • DCTH N/A
  • Fundamental
  • Price
  • PBPB $12.25
  • DCTH $13.57
  • Analyst Decision
  • PBPB Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • PBPB 3
  • DCTH 4
  • Target Price
  • PBPB $15.67
  • DCTH $24.00
  • AVG Volume (30 Days)
  • PBPB 233.9K
  • DCTH 734.6K
  • Earning Date
  • PBPB 08-07-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • PBPB N/A
  • DCTH N/A
  • EPS Growth
  • PBPB 1009.90
  • DCTH N/A
  • EPS
  • PBPB 1.39
  • DCTH N/A
  • Revenue
  • PBPB $465,126,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • PBPB $4.74
  • DCTH $155.42
  • Revenue Next Year
  • PBPB $4.48
  • DCTH $37.93
  • P/E Ratio
  • PBPB $8.82
  • DCTH N/A
  • Revenue Growth
  • PBPB N/A
  • DCTH 1068.87
  • 52 Week Low
  • PBPB $6.28
  • DCTH $7.17
  • 52 Week High
  • PBPB $13.48
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • PBPB 65.44
  • DCTH 38.26
  • Support Level
  • PBPB $10.51
  • DCTH $12.98
  • Resistance Level
  • PBPB $12.18
  • DCTH $14.18
  • Average True Range (ATR)
  • PBPB 0.43
  • DCTH 0.68
  • MACD
  • PBPB 0.04
  • DCTH -0.28
  • Stochastic Oscillator
  • PBPB 80.84
  • DCTH 15.95

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: